IP Library Granted Patent US 10,960,225
Granted Patent B2
US 10,960,225 · App. 16/156,833 · Granted Mar 30, 2021

Systems and methods for preventing, mitigating, and/or treating dementia via visual stimulation that binds higher order brain regions, reduces neurodegeneration and neuroinflammation, and improves cognitive function

Inventors: Chinnakkaruppan Adaikkan (Somerville, MA); Li-Huei Tsai (Cambridge, MA)
Assignee: Massachusetts Institute of Technology
A61N5/0622A61N5/0618A61N5/1001A61N2005/0626A61N2005/0652
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,960,225
App. No.
16/156,833
Granted
Mar 30, 2021
Kind
B2
Abstract

Devices, systems, and methods for treating dementia or Alzheimer's disease in a subject in need thereof. In one example, chronic visual stimuli having a frequency of about 30 Hz to about 50 Hz, and more specifically about 40 Hz, are non-invasively delivered to the subject to entrain gamma oscillations in multiple brain regions of the subject, including the prefrontal cortex (PFC) and the hippocampus. The entrained gamma oscillations modulate neuronal activity across multiple brain regions (e.g., facilitate functional binding of neural networks at low gamma frequencies) to induce various neuroprotective effects (e.g., amelioration of amyloid plaques and tau hyper-phosphorylation) and reduce neurodegeneration. Neuronal activity mediated by the chronic visual stimuli reduces an immune response in microglia and ameliorates aberrantly modified genes and proteins involved in membrane trafficking, intracellular transport, synaptic function, neuroinflammation and DNA damage response. Behavior modification including enhanced learning and memory is observed.

Claims (104)

1. A method for treating dementia or Alzheimer's disease in a subject in need thereof, the method comprising:

A) non-invasively delivering chronic visual stimuli having a frequency of about 30 Hz to about 50 Hz and having a 50% duty cycle to the subject for at least 1 hour per day for at least 22 days to entrain synchronized gamma oscillations in multiple brain regions of the subject including at least the prefrontal cortex (PFC) and the hippocampus of the subject.

2. The method of claim 1 , wherein in A), the chronic visual stimuli have a frequency of about 35 Hz to about 45 Hz.

3. The method of claim 2 , wherein in A), the chronic visual stimuli have a frequency of about 40 Hz.

4. The method of claim 3 , wherein A) comprises inducing local field potential (LFP) at about 40 Hz in at least the prefrontal cortex and the hippocampus of the subject.

5. The method of claim 2 , wherein A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimuli.

6. The method of claim 5 , wherein:

the square wave current signal has the 50% duty cycle; and

a frequency of the square wave current signal is equal to or approximately 40 Hz.

7. The method of claim 6 , wherein A) comprises inducing local field potential (LFP) at about 40 Hz in at least the prefrontal cortex and the hippocampus of the subject.

8. The method of claim 1 , wherein A) comprises non-invasively delivering the chronic visual stimuli for at least 1 hour per day for at least 42 days.

9. The method of claim 8 , wherein:

A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimuli;

the square wave current signal has the 50% duty cycle; and

a frequency of the square wave current signal is equal to or approximately 40 Hz.

10. The method of claim 9 , wherein A) comprises inducing local field potential (LFP) at about 40 Hz in at least the prefrontal cortex and the hippocampus of the subject.

11. The method of claim 10 , wherein the multiple brain regions of the subject include the visual cortex, the somatosensory cortex, the hippocampus and the prefrontal cortex of the subject.

12. The method of claim 1 , wherein A) comprises:

A1) non-invasively delivering the chronic visual stimuli having the frequency of about 30 Hz to about 50 Hz to the subject to concurrently entrain synchronized gamma oscillations in the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject.

13. The method of claim 12 , wherein A1) comprises:

significantly increasing gamma coherence having a frequency between 30 Hz to 50 Hz between the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject.

14. The method of claim 13 , wherein the multiple brain regions of the subject include the visual cortex, the somatosensory cortex, the hippocampus and the prefrontal cortex of the subject.

15. The method of claim 14 , wherein in A), the chronic visual stimuli have a frequency of about 35 Hz to about 45 Hz.

16. The method of claim 15 , wherein in A), the chronic visual stimuli have a frequency of about 40 Hz.

17. The method of claim 13 , wherein A) comprises non-invasively delivering the chronic visual stimuli for at least I hour per day for at least 42 days.

18. The method of claim 17 , wherein:

A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimuli;

the square wave current signal has the 50% duty cycle; and

a frequency of the square wave current signal is equal to or approximately 40 Hz.

19. The method of claim 12 , wherein A1) further comprises:

A2) non-invasively delivering the chronic visual stimuli having the frequency of about 30 Hz to about 50 Hz to modulate neuronal activity between the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject.

20. The method of claim 19 , wherein A2) further comprises:

non-invasively delivering the chronic visual stimuli having the frequency of about 30 Hz to about 50 Hz to coordinate neuronal activity between the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject.

21. The method of claim 20 , wherein the multiple brain regions of the subject include the visual cortex, the somatosensory cortex, the hippocampus and the prefrontal cortex of the subject.

22. The method of claim 21 , wherein in A), the chronic visual stimuli have a frequency of about 35 Hz to about 45 Hz.

23. The method of claim 22 , wherein in A), the chronic visual stimuli have a frequency of about 40 Hz.

24. The method of claim 19 , wherein A) comprises non-invasively delivering the chronic visual stimuli for at least 1 hour per day for at least 42 days.

25. The method of claim 22 , wherein:

A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimuli;

the square wave current signal has the 50% duty cycle; and

a frequency of the square wave current signal is equal to or approximately 40 Hz.

26. The method of claim 19 , wherein A2) further comprises:

A3) non-invasively delivering the chronic visual stimuli having the frequency of about 30 Hz to about 50 Hz to reduce neurodegeneration in the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject.

27. The method of claim 26 , wherein A3) further comprises:

non-invasively delivering the chronic visual stimuli having the frequency of about 30 Hz to about 50 Hz to reduce amyloid plaques in the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject.

28. The method of claim 26 , wherein A3) further comprises:

non-invasively delivering the chronic visual stimuli having the frequency of about 30 Hz to about 50 Hz to reduce tau hyper-phosphorylation in the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject.

29. The method of claim 26 , wherein A3) further comprises:

non-invasively delivering the chronic visual stimuli having the frequency of about 30 Hz to about 50 Hz to reduce loss of neurons and synapses in the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject.

30. The method of claim 26 , wherein A3) further comprises:

non-invasively delivering the chronic visual stimuli having the frequency of about 30 Hz to about 50 Hz to reduce brain atrophy in the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject.

31. The method of claim 26 , wherein A3) further comprises:

non-invasively delivering the chronic visual stimuli having the frequency of about 30 Hz to about 50 Hz to reduce ventricle expansion in the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject.

32. The method of claim 26 , wherein A) comprises non-invasively delivering the chronic visual stimuli for at least 1 hour per day for at least 42 days.

33. The method of claim 32 , wherein:

A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimuli;

the square wave current signal has the 50% duty cycle; and

a frequency of the square wave current signal is equal to or approximately 40 Hz.

34. The method of claim 27 , wherein A) comprises non-invasively delivering the chronic visual stimuli for at least 1 hour per day for at least 42 days.

35. The method of claim 34 , wherein:

A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimuli;

the square wave current signal has the 50% duty cycle; and

a frequency of the square wave current signal is equal to or approximately 40 Hz.

36. The method of claim 19 , wherein A2) further comprises:

A3) non-invasively delivering the chronic visual stimuli having the frequency of about 30 Hz to about 50 Hz to reduce neuroinflammation in the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject.

37. The method of claim 36 , wherein A3) further comprises:

A4) non-invasively delivering the chronic visual stimuli having the frequency of about 30 Hz to about 50 Hz to reduce an immune response of at least some microglia in the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject.

38. The method of claim 37 , wherein A4) further comprises:

non-invasively delivering the chronic visual stimuli having the frequency of about 30 Hz to about 50 Hz to morphologically transform the at least some microglia in the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject.

39. The method of claim 37 , wherein A4) further comprises:

non-invasively delivering the chronic visual stimuli having the frequency of about 30 Hz to about 50 Hz to increase protein degradation in the at least some microglia in the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject.

40. The method of claim 37 , wherein A) comprises non-invasively delivering the chronic visual stimuli for at least 1 hour per day for at least 42 days.

41. The method of claim 40 , wherein:

A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimuli;

the square wave current signal has the 50% duty cycle; and

a frequency of the square wave current signal is equal to or approximately 40 Hz.

42. The method of claim 19 , wherein A2) further comprises:

non-invasively delivering the chronic visual stimuli having the frequency of about 30 Hz to about 50 Hz to ameliorate aberrantly modified genes and proteins involved in at least one of membrane trafficking, intracellular transport, synaptic function, neuroinflammation, apoptotic process, and DNA damage in the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject.

43. The method of claim 12 , wherein A1) further comprises:

A2) non-invasively delivering the chronic visual stimuli having the frequency of about 30 Hz to about 50 Hz to enhance learning and memory of the subject.

44. The method of claim 43 , wherein A) comprises non-invasively delivering the chronic visual stimuli for at least I hour per day for at least 42 days.

45. The method of claim 44 , wherein:

A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimuli;

the square wave current signal has the 50% duty cycle; and

a frequency of the square wave current signal is equal to or approximately 40 Hz.

46. A method for treating dementia or Alzheimer's disease in a subject in need thereof, the method comprising:

A) non-invasively delivering chronic visual stimuli having a frequency of about 30 Hz to about 50 Hz to the subject to entrain synchronized gamma oscillations in multiple brain regions of the subject including at least the prefrontal cortex (PFC) and the hippocampus of the subject, wherein A) comprises non-invasively delivering the chronic visual stimuli having the frequency of about 30 Hz to about 50 Hz to the subject to:

A1) concurrently entrain synchronized gamma oscillations in the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject;

A2) coordinate neuronal activity between the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject;

A3) reduce neurodegeneration in the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject;

A4) reduce neuroinflammation in the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject;

A5) ameliorate aberrantly modified genes and proteins involved in at least one of membrane trafficking, intracellular transport, synaptic function, neuroinflammation, apoptotic process, and DNA damage in the multiple brain regions of the subject including at least the prefrontal cortex and the hippocampus of the subject; and

A6) enhance learning and memory of the subject.

47. The method of claim 46 , wherein A) comprises inducing local field potential (LFP) at about 40 Hz in at least the prefrontal cortex and the hippocampus of the subject.

48. The method of claim 47 , wherein A) comprises non-invasively delivering the chronic visual stimuli for at least 1 hour per day for at least 22 days.

49. The method of claim 48 , wherein A) comprises non-invasively delivering the chronic visual stimuli for at least 1 hour per day for at least 42 days.

50. The method of claim 48 , wherein:

A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimuli;

the square wave current signal has a 50% duty cycle; and

a frequency of the square wave current signal is equal to or approximately 40 Hz.

51. The method of claim 46 , wherein:

A) comprises driving an array of light emitting diodes (LEDs) with a square wave current signal to generate the chronic visual stimuli;

the square wave current signal has a 50% duty cycle; and

a frequency of the square wave current signal is equal to or approximately 40 Hz.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2018
From: ADAIKKAN, CHINNAKKARUPPAN; TSAI, LI-HUEI
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 047197/0504 →
Continuity (4)
Continuation In Part 16135938 · Sep 19, 2018
Provisional Application 62570929 · Oct 11, 2017
Provisional Application 62570250 · Oct 10, 2017
Related Publication 20190126062A1 · May 2, 2019
Cited By (8)
US 12,296,106 US 12,296,188 US 12,311,194 US 12,318,549 US 12,381,011 US 12,434,072 US 12,515,069 US 12,543,250